Antisense Molecules and Methods for Treating Pathologies

An antisense molecule capable of binding to a selected target site to induce exon skipping in the dystrophin gene, as set forth in SEQ ID NO: 1 to 59.

Patents:
WO 2,011,057,350

Inventor(s): WILTON STEPHEN [AU]; FLETCHER SUE [AU]; ADAMS ABBIE [AU]; MELONI PENNY [AU]

Type of Offer: Sale